Universal vaccine against SARS-CoV-2 variants based on conserved spike protein epitopes – vaccine efficacy studies in vitro and in vivo.
2021/41/B/NZ6/02888
Keywords
Descriptors
- NZ6_005: Wirusologia
- NZ7_012: Prewencja chorób człowieka
Panel
NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution
Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego
Voivodeship: pomorskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 5
Call
OPUS 21 – announced on 2021-03-15
- Amount awarded
- 1 286 400 PLN
- Project start date
- 2022-03-01
- Project end date
- 2027-02-28
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.